FDA tells GLP-1 makers to warn of potential vision loss side effect
· washingtonpost.com · popularity 40/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at washingtonpost.com →
Summary
The agency is requiring GLP-1 manufacturers to warn the drugs can increase risk of “eye stroke.”
Found in: Washington Post National. Rating basis: single outlet; outlet tier 5; 1 feeds; feed position 1.